Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Orphazyme A/S News

    144,50 € +5,86% +8,00 €
    26.04.24 21:43:31 Gettex aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3EYNB
    ISIN: DK0062502894
    US-Symbol: OZYMF
    Typ: Aktie

    Orphazyme A/S News

    18.05.22 - PLX
    Orphazyme to Submit Restructuring Proposal Following Asset Sales Agreement with KemPharm
    (PLX AI) – Orphazyme plans to present the proposal to Danish High Court and all known creditors and will be voted on at a meeting on 30 May. • Orphazyme: if restructuring proposal is ...
    29.04.22 - PLX
    Orphazyme Received Non-Binding Offers; Vast Majority of Proceeds Would Go to Creditors
    (PLX AI) – Orphazyme has to date received certain non-​binding offers (the “Offers”) to purchase all of Orphazyme’s assets and operations. • Orphazyme vast majority of the consideration ...
    22.03.22 - PLX
    Orphazymes Withdraws EMA Application for Arimoclomol
    (PLX AI) – Orphazyme announces withdrawal of European Marketing Authorisation Application for arimoclomol for the treatment of Niemann-​Pick disease type C. • Receipt of the ...
    23.02.22 - PLX
    Orphazyme Says Arimoclomol Unlikely to Be Approved Next Month by EMA
    (PLX AI) – Orphazyme notified by the CHMP of a negative trend vote on the MAA for arimoclomol in NPC. • The trend vote indicates that the CHMP's current orientation is to not approve ...
    18.01.22 - PLX
    Orphazyme Sees Smaller Operating Loss After Cutting Expenses
    (PLX AI) – Orphazyme updates 2021 financial outlook. • Orphazyme 2021 Net revenue range narrowed to DKK 35 – 37 million from DKK 30-40 million • Orphazyme 2021 Operating ...
    05.10.21 - PLX
    Orphazyme Now Sees Higher Cash Reserves at End of 2021
    (PLX AI) – Orphazyme now expects to end 2021 with a cash position of no less than DKK 80 million, up from about DKK 50 million guided previously. • The improved cash guidance ...
    31.08.21 - PLX
    Orphazyme H1 Net Loss Bigger Than Expected; Operating Loss Outlook Unchanged
    (PLX AI) – Orphazyme half year net income DKK -463.8 million vs. estimate DKK -405 million. • Outlook FY operating loss DKK 670-700 million (unchanged) • Orphazyme recognized ...
    11.06.21 - Der Aktionär
    1.400 Prozent an einem Tag! Irrsinn bei dänischer Meme‑Aktie

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »